BIOCLONE Anti-Kell (Kel1) Monoclonal IgM (human) - Indonesia BPOM Medical Device Registration

BIOCLONE Anti-Kell (Kel1) Monoclonal IgM (human) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20209320538. The device is manufactured by MILLIPORE UK LTD from United Kingdom, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is EMERALINDO ASIA PACIFIC.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.